Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$649M |
| 2 |
Weyerhaeuser
WY
|
+$353M |
| 3 |
IQVIA
IQV
|
+$135M |
| 4 |
Halliburton
HAL
|
+$135M |
| 5 |
Dover
DOV
|
+$119M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.73B |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$709M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
+$468M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$261M |
Sector Composition
| 1 | Technology | 14.2% |
| 2 | Healthcare | 11.67% |
| 3 | Financials | 10.34% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Communication Services | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Entravision Communication
EVC
$214M
| $80K | ﹤0.01% |
13,966
+13,223
| +1,780% | +$75.7K |
|
2702
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.09B
| $80K | ﹤0.01% |
645
| – | – |
|
2703
GDS Holdings
GDS
$7.18B
| $80K | ﹤0.01% |
+7,100
| New | +$80K |
|
2704
Ironwood Pharmaceuticals
IRWD
$205M
| $80K | ﹤0.01% |
6,089
+4,602
| +309% | +$60.5K |
|
2705
ProShares Ultra Financials
UYG
$890M
| $80K | ﹤0.01% |
2,115
+2,013
| +1,974% | +$76.1K |
|
2706
Westamerica Bancorp
WABC
$1.24B
| $80K | ﹤0.01% |
1,352
-1,974
| -59% | -$117K |
|
|
ELLI
2707
DELISTED
Ellie Mae Inc
ELLI
| $80K | ﹤0.01% |
985
-29,054
| -97% | -$2.36M |
|
|
BELFB
2708
Bel Fuse Class B
BELFB
$1.84B
| $79K | ﹤0.01% |
2,533
+1,292
| +104% | +$40.3K |
|
2709
First Interstate BancSystem
FIBK
$3.41B
| $79K | ﹤0.01% |
2,069
-2,513
| -55% | -$96K |
|
2710
Karyopharm Therapeutics
KPTI
$57.8M
| $79K | ﹤0.01% |
477
-1,963
| -80% | -$325K |
|
2711
Stagwell
STGW
$1.42B
| $79K | ﹤0.01% |
7,157
+7,118
| +18,251% | +$78.6K |
|
2712
Theravance Biopharma
TBPH
$721M
| $79K | ﹤0.01% |
2,330
+563
| +32% | +$19.1K |
|
2713
Trustco Bank Corp NY
TRST
$745M
| $79K | ﹤0.01% |
1,768
-775
| -30% | -$34.6K |
|
2714
BioCryst Pharmaceuticals
BCRX
$1.69B
| $78K | ﹤0.01% |
14,895
-147,821
| -91% | -$774K |
|
2715
Northwest Natural Holdings
NWN
$1.73B
| $78K | ﹤0.01% |
1,222
-2,919
| -70% | -$186K |
|
2716
Real Estate Select Sector SPDR Fund
XLRE
$7.82B
| $78K | ﹤0.01% |
2,441
-4,329
| -64% | -$138K |
|
|
INVX
2717
Innovex International, Inc.
INVX
$1.15B
| $78K | ﹤0.01% |
1,774
-17,542
| -91% | -$771K |
|
2718
Esperion Therapeutics
ESPR
$567M
| $77K | ﹤0.01% |
1,539
-76,167
| -98% | -$3.81M |
|
2719
iShares US Financials ETF
IYF
$4.08B
| $77K | ﹤0.01% |
1,366
+400
| +41% | +$22.5K |
|
2720
Rapid7
RPD
$1.29B
| $77K | ﹤0.01% |
4,347
-1,183
| -21% | -$21K |
|
2721
iPath Select MLP ETN
ATMP
$506M
| $76K | ﹤0.01% |
3,575
| – | – |
|
2722
Cidara Therapeutics
CDTX
$1.63B
| $76K | ﹤0.01% |
470
-575
| -55% | -$93K |
|
2723
Ceragon Networks
CRNT
$179M
| $76K | ﹤0.01% |
+36,600
| New | +$76K |
|
2724
FirstCash
FCFS
$6.56B
| $76K | ﹤0.01% |
1,194
-7,116
| -86% | -$453K |
|
|
IRS
2725
IRSA Inversiones y Representaciones
IRS
$938M
| $76K | ﹤0.01% |
3,219
+2,388
| +287% | +$56.4K |
|